TY - JOUR
T1 - Health equity and the usage of atypical antipsychotics within the Brazilian national health system
T2 - findings and implications
AU - Zuppo, Isabella de Figueiredo
AU - Ruas, Cristina Mariano
AU - de Oliveira, Helian Nunes
AU - Godman, Brian
AU - Castel, Saulo
AU - Wainberg, Milton L.
AU - Reis, Edna Afonso
N1 - Funding Information:
This project was supported directly or indirectly by Capes (Coordenação de Aperfeiçoamento de Pessoal do Nível Superior), CNPq (Conselho Nacional de DesenvolvimentoCientífico e Tecnológico) and Fapemig (Fundação de Amparo à Pesquisa de Minas Gerais).
Funding Information:
A reviewer on this manuscript has disclosed receiving manuscript or speaker’s fees from Astellas, Dainippon Sumitomo Pharma, Eisai, Eli Lilly, Elsevier Japan, Janssen Pharmaceuticals, Kyowa Yakuhin, Meiji Seika Pharma, Mitsubishi Tanabe Pharma, MSD, Novartis, Otsuka Pharmaceutical, Shionogi, Shire, Tsumura, Wiley Japan, and Yoshitomi Yakuhin, and research grants from Eisai, Mochida Pharmaceutical, Meiji Seika Pharma and Shionogi. Peer reviewers on this manuscript have no other relevant financial relationships or otherwise to disclose.
Publisher Copyright:
© 2020 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2021
Y1 - 2021
N2 - Background: There is a need to evaluate the health equity of atypical antipsychotics users who obtain their medicines from the Brazilian National Health System (SUS) through the identification of key factors that influence their health status due to concerns with equity of care. Research design and methods: Cross-sectional study among patients attending state pharmacies in Brazil. Individuals were included if they used atypical antipsychotics, aged ≥18 years, and answered the EQ-5D-3 L questionnaire. Sociodemographic, behavioral, and clinical data were collected. The dependent variable was health status. Associations between the independent variables and the dependent variable were analyzed by adjusting a linear regression model. Results: Overall, 388 individuals met the eligibility criteria and were included in the analysis. The final multiple linear regression model demonstrated a statistically significant association between VAS and suicide attempts, private care, current antipsychotics, comorbidities, and perceived family support. Expert Commentary: The study identified several factors both individual and collective that correlate with the health status of atypical antipsychotic users and confirmed the importance of providing medicines for treating psychotic disorders. However, other factors are involved including social support. Our results suggest additional activities and policies are necessary including strategies to address the differences in private and public health care.
AB - Background: There is a need to evaluate the health equity of atypical antipsychotics users who obtain their medicines from the Brazilian National Health System (SUS) through the identification of key factors that influence their health status due to concerns with equity of care. Research design and methods: Cross-sectional study among patients attending state pharmacies in Brazil. Individuals were included if they used atypical antipsychotics, aged ≥18 years, and answered the EQ-5D-3 L questionnaire. Sociodemographic, behavioral, and clinical data were collected. The dependent variable was health status. Associations between the independent variables and the dependent variable were analyzed by adjusting a linear regression model. Results: Overall, 388 individuals met the eligibility criteria and were included in the analysis. The final multiple linear regression model demonstrated a statistically significant association between VAS and suicide attempts, private care, current antipsychotics, comorbidities, and perceived family support. Expert Commentary: The study identified several factors both individual and collective that correlate with the health status of atypical antipsychotic users and confirmed the importance of providing medicines for treating psychotic disorders. However, other factors are involved including social support. Our results suggest additional activities and policies are necessary including strategies to address the differences in private and public health care.
KW - Antipsychotic agents
KW - health equity
KW - health status disparities
KW - psychotic disorders
KW - schizophrenia spectrum and other psychotic disorders
UR - http://www.scopus.com/inward/record.url?scp=85089959598&partnerID=8YFLogxK
U2 - 10.1080/14737167.2020.1804873
DO - 10.1080/14737167.2020.1804873
M3 - Article
C2 - 32779944
AN - SCOPUS:85089959598
SN - 1473-7167
VL - 21
SP - 743
EP - 751
JO - Expert Review of Pharmacoeconomics and Outcomes Research
JF - Expert Review of Pharmacoeconomics and Outcomes Research
IS - 4
ER -